Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests.
Brian David NicholsonTim JamesMaria PaddonSteve JusticeJason L OkeJames Edward EastBrian ShinePublished in: Alimentary pharmacology & therapeutics (2020)
A FIT threshold of ≥10 µg Hb/g faeces would be appropriate to triage adult patients presenting to primary care with symptoms of serious colorectal disease. FIT may be used to reprioritise patients referred with colorectal cancer symptoms whose investigations have been delayed by the COVID-19 pandemic.